From San Diego, at a meeting of the American Society of Hematology
Two experimental pills can send chronic myeloid leukemia into remission in some patients who don’t benefit from the best available medicine, early results from three studies show.
In many patients with this blood cancer, the genes encoding proteins called Bcr and Abl become fused.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.